Tolcapone

TargetMol
Product Code: TAR-T6708
Supplier: TargetMol
CodeSizePrice
TAR-T6708-5mg5mg£98.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6708-10mg10mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6708-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6708-25mg25mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6708-50mg50mg£151.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6708-100mg100mg£179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6708-200mg200mg£222.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Tolcapone is a catechol-O-methyltransferase inhibitor used in the therapy of Parkinson disease as adjunctive therapy in combination with levodopa and carbidopa.
CAS:
134308-13-7
Formula:
C14H11NO5
Molecular Weight:
273.244
Pathway:
Metabolism; Apoptosis; Neuroscience
Purity:
0.9989
SMILES:
Cc1ccc(cc1)C(=O)c1cc(O)c(O)c(c1)[N+]([O-])=O
Target:
Apoptosis; Beta Amyloid; Transferase

References

Qiu M, Li Z, Chen Y, et al. Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses. Frontiers in Microbiology. 2020, 11: 504. Z?rcher G, et al. Adv Neurol, 1990, 53:497-50 Brannan T, et al. Neurology, 1992, 42(3 Pt 1), 683-685. Z?rcher G, et al. J Neural Transm Suppl, 1990, 32, 375-38 Vieira-Coelho MA, et al. Br J Pharmacol, 1996, 117(3), 516-520. Qiu M, Li Z, Chen Y, et al. Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses. Frontiers in Microbiology. 2020, 11: 504 Maj J, et al. J Neural Transm Park Dis Dement Sect, 1990, 2(2), 101-112.